home / stock / imiay / imiay news
Despite positive contributions from the company's biopharma exposure, sharp declines in short-cycle industrial, longer-cycle process, and municipal markets have hit IDEX's revenue and margins quite hard. Biopharma production, including therapeutics and vaccines, offers good long-term ...
Even with above-average exposure to weak power-gen and oil/gas markets, IMI outperformed most industrial conglomerates in 1H'20, with fairly broad underlying outperformance. Precision offers the most near-term upside, with recoveries in factory automation and commercial vehicles, as w...
On the whole, I’ve liked Alfa Laval ( OTCPK:ALFVY ) more than the Street, and that has worked out okay, with the stock more or less performing in line with the S&P and beating its industrial peer group. Now, though, the company has made a controversial decision to pay a high premi...
IMI PLC (IMIAF) Q4 2019 Earnings Conference Call February 28, 2020, 03:30 ET Company Participants Roy Twite - CEO & Director Daniel Shook - Finance Director & Director Massimo Grassi - Divisional MD, IMI Precision Engineering Conference Call Participants Max Yates -...
The following slide deck was published by IMI plc in conjunction with their 2019 Q4 earnings Read more ...